A test that analyzes fetal DNA found in a pregnant woman’s blood proved much more accurate in screening for Down syndrome and another chromosomal disorder than the now-standard blood test, a new study has found. Michael Greene, professor of obstetrics, gynecology and reproductive biology at Massachusetts General Hospital, is the coauthor of an editorial accompanying the study.
